Skip to main content

Table 5 Incremental cost-effectiveness ratio (ICER) for clinicians' adherence versus non adherence to clinical practice guidelines (CPGs)

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

 

Mean cost per patient(€, 2009)

Mean Incremental Cost[[]](€, 2009)

Mean effectiveness per patient(Relapse-free survival, years)

Mean Incremental Effectiveness[[]](Relapse-free survival, years)

ICER(€ per relapse-free year gained)[[]]

Overall management CPG (+)

23,571

-

2.46

-

 

Overall management CPG (-)

27,313

3,742

2.16

-0.30

Dominated